aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 3.91 USD -1.51%
Market Cap: 328.2m USD
Have any thoughts about
aTyr Pharma Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

-3.9
Current
-2.5
Median
3.9
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-3.9
=
Enterprise Value
263.2m USD
/
FCFF
-67.1m USD
All Countries
Close
Market Cap EV/FCFF
US
aTyr Pharma Inc
NASDAQ:ATYR
328.2m USD -3.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 513.6
US
Abbvie Inc
NYSE:ABBV
315.6B USD 23.5
US
Amgen Inc
NASDAQ:AMGN
140.4B USD 30
US
Gilead Sciences Inc
NASDAQ:GILD
113.3B USD 10.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.2B USD -71.6
US
Epizyme Inc
F:EPE
94.1B EUR -468.3
AU
CSL Ltd
ASX:CSL
138.1B AUD 63.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.2B USD 21.9
US
Seagen Inc
F:SGT
39.3B EUR -56.5
NL
argenx SE
XBRU:ARGX
37.3B EUR -109.8
 
US
aTyr Pharma Inc
NASDAQ:ATYR
Average EV/FCFF: 30
Negative Multiple: -3.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 513.6
US
Abbvie Inc
NYSE:ABBV
23.5
US
Amgen Inc
NASDAQ:AMGN
30
US
Gilead Sciences Inc
NASDAQ:GILD
10.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -71.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -468.3
AU
CSL Ltd
ASX:CSL
63.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.8

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A